CEA Protéine

N° du produit ABIN934506

Détail du produit

Antigène: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Type de proteíne: Native

Origine: Humain

Source: Human

Attributs du produit: Purified native Human CEA protein (Preservative-free)
Protein Source: Purified human colon carcinoma

Pureté: > 80 % pure

Information d'application

Indications d'application: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied as a liquid in 10 mM PBS, pH 7.5, with no preservatives.

Agent conservateur: Without preservative

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20 °C.

Référence

Lima, Jenkins, Guerrero, Triozzi, Shaw, Strong: "A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF)." dans: Vaccine, Vol. 23, Issue 10, pp. 1273-83, (2005) (PubMed).

Détail du antigène

Antigène: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Autre désignation: CEA (CEA Produits)

Synonymes: RGD1311281 Protein, carcinoembryonic antigen-related cell adhesion molecule 20 Protein, carcinoembryonic antigen gene family Protein, Ceacam20 Protein, Cea Protein

Sujet: Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production of CEA stops before birth. Therefore, it is not usually present in the blood of healthy adults, although levels are raised in heavy smokers. CEA is a glycosyl phosphatidyl inositol (GPI)-cell surface anchored glycoprotein whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells.
Description: Purified human colon carcinoma.
Alternative Names: Carcinoembryonic Antigen protein